Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient.
AFIAS Free Anti-Golimumab can detect the presence of anti-drug antibodies against
Golimumab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 10 minutes.
This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.
Reagents, Therapeutic Drug Monitoring
Free Anti-Golimumab
Detecting the development of Anti-drug antibodies (ADAs) against Golimumab in patients being treated with Golimumab for chronic autoimmune and inflammatory conditions
Reviews
There are no reviews yet.